NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors
about
NUP214-ABL1 fusion defines a rare subtype of B-cell precursor acute lymphoblastic leukemia that could benefit from tyrosine kinase inhibitors
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 December 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
NUP214-ABL1 fusion defines a r ...... rom tyrosine kinase inhibitors
@en
NUP214-ABL1 fusion defines a r ...... om tyrosine kinase inhibitors.
@nl
type
label
NUP214-ABL1 fusion defines a r ...... rom tyrosine kinase inhibitors
@en
NUP214-ABL1 fusion defines a r ...... om tyrosine kinase inhibitors.
@nl
prefLabel
NUP214-ABL1 fusion defines a r ...... rom tyrosine kinase inhibitors
@en
NUP214-ABL1 fusion defines a r ...... om tyrosine kinase inhibitors.
@nl
P2093
P2860
P50
P1433
P1476
NUP214-ABL1 fusion defines a r ...... rom tyrosine kinase inhibitors
@en
P2093
Bénédicte Bruno
Emmanuelle Clappier
Martin Alarcon Fuentes
Wadih Abou Chahla
P2860
P304
P356
10.3324/HAEMATOL.2015.136499
P50
P577
2015-12-17T00:00:00Z